Global Immuno-oncology Diagnosis Market Growth (Status and Outlook) 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Immuno-oncology Diagnosis Market Size 2016-2026

2.1.2 Immuno-oncology Diagnosis Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Immuno-oncology Diagnosis Segment by Technology

2.2.1 PCR

2.2.2 PCR

2.2.3 Immunoassay

2.3 Immuno-oncology Diagnosis Market Size by Technology

2.3.1 Global Immuno-oncology Diagnosis Market Size CAGR by Technology

2.3.2 Global Immuno-oncology Diagnosis Market Size Market Share by Technology (2016-2021)

2.4 Immuno-oncology Diagnosis Segment by Application

2.4.1 Research

2.4.2 Diagnostics

2.5 Immuno-oncology Diagnosis Market Size by Application

2.5.1 Global Immuno-oncology Diagnosis Market Size CAGR by Application

2.5.2 Global Immuno-oncology Diagnosis Market Size Market Share by Application (2016-2021)

3 Immuno-oncology Diagnosis Market Size by Players

3.1 Immuno-oncology Diagnosis Market Size Market Share by Players

3.1.1 Global Immuno-oncology Diagnosis Revenue by Players (2019-2021E)

3.1.2 Global Immuno-oncology Diagnosis Revenue Market Share by Players (2019-2021E)

3.2 Global Immuno-oncology Diagnosis Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Immuno-oncology Diagnosis by Regions

4.1 Immuno-oncology Diagnosis Market Size by Regions (2016-2021)

4.2 Americas Immuno-oncology Diagnosis Market Size Growth (2016-2021)

4.3 APAC Immuno-oncology Diagnosis Market Size Growth (2016-2021)

4.4 Europe Immuno-oncology Diagnosis Market Size Growth (2016-2021)

4.5 Middle East & Africa Immuno-oncology Diagnosis Market Size Growth (2016-2021)

5 Americas

5.1 Americas Immuno-oncology Diagnosis Market Size by Country (2016-2021)

5.2 Americas Immuno-oncology Diagnosis Market Size by Technology (2016-2021)

5.3 Americas Immuno-oncology Diagnosis Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Immuno-oncology Diagnosis Market Size by Region (2016-2021)

6.2 APAC Immuno-oncology Diagnosis Market Size by Technology (2016-2021)

6.3 APAC Immuno-oncology Diagnosis Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Immuno-oncology Diagnosis by Country (2016-2021)

7.2 Europe Immuno-oncology Diagnosis Market Size by Technology (2016-2021)

7.3 Europe Immuno-oncology Diagnosis Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Immuno-oncology Diagnosis by Region (2016-2021)

8.2 Middle East & Africa Immuno-oncology Diagnosis Market Size by Technology (2016-2021)

8.3 Middle East & Africa Immuno-oncology Diagnosis Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Immuno-oncology Diagnosis Market Forecast

10.1 Global Immuno-oncology Diagnosis Forecast by Regions (2021-2026)

10.1.1 Global Immuno-oncology Diagnosis Forecast by Regions (2021-2026)

10.1.2 Americas Immuno-oncology Diagnosis Forecast

10.1.3 APAC Immuno-oncology Diagnosis Forecast

10.1.4 Europe Immuno-oncology Diagnosis Forecast

10.1.5 Middle East & Africa Immuno-oncology Diagnosis Forecast

10.2 Americas Immuno-oncology Diagnosis Forecast by Countries (2021-2026)

10.2.1 United States Immuno-oncology Diagnosis Market Forecast

10.2.2 Canada Immuno-oncology Diagnosis Market Forecast

10.2.3 Mexico Immuno-oncology Diagnosis Market Forecast

10.2.4 Brazil Immuno-oncology Diagnosis Market Forecast

10.3 APAC Immuno-oncology Diagnosis Forecast by Region (2021-2026)

10.3.1 China Immuno-oncology Diagnosis Market Forecast

10.3.2 Japan Immuno-oncology Diagnosis Market Forecast

10.3.3 Korea Immuno-oncology Diagnosis Market Forecast

10.3.4 Southeast Asia Immuno-oncology Diagnosis Market Forecast

10.3.5 India Immuno-oncology Diagnosis Market Forecast

10.3.6 Australia Immuno-oncology Diagnosis Market Forecast

10.4 Europe Immuno-oncology Diagnosis Forecast by Country (2021-2026)

10.4.1 Germany Immuno-oncology Diagnosis Market Forecast

10.4.2 France Immuno-oncology Diagnosis Market Forecast

10.4.3 UK Immuno-oncology Diagnosis Market Forecast

10.4.4 Italy Immuno-oncology Diagnosis Market Forecast

10.4.5 Russia Immuno-oncology Diagnosis Market Forecast

10.5 Middle East & Africa Immuno-oncology Diagnosis Forecast by Region (2021-2026)

10.5.1 Egypt Immuno-oncology Diagnosis Market Forecast

10.5.2 South Africa Immuno-oncology Diagnosis Market Forecast

10.5.3 Israel Immuno-oncology Diagnosis Market Forecast

10.5.4 Turkey Immuno-oncology Diagnosis Market Forecast

10.5.5 GCC Countries Immuno-oncology Diagnosis Market Forecast

10.6 Global Immuno-oncology Diagnosis Forecast by Technology (2021-2026)

10.7 Global Immuno-oncology Diagnosis Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 10x Genomics

11.1.1 10x Genomics Company Information

11.1.2 10x Genomics Immuno-oncology Diagnosis Product Offered

11.1.3 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 10x Genomics Main Business Overview

11.1.5 10x Genomics Latest Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Information

11.2.2 Abbott Laboratories Immuno-oncology Diagnosis Product Offered

11.2.3 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Abbott Laboratories Main Business Overview

11.2.5 Abbott Laboratories Latest Developments

11.3 Abcam

11.3.1 Abcam Company Information

11.3.2 Abcam Immuno-oncology Diagnosis Product Offered

11.3.3 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Abcam Main Business Overview

11.3.5 Abcam Latest Developments

11.4 Adaptive Biotechnologies

11.4.1 Adaptive Biotechnologies Company Information

11.4.2 Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offered

11.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Adaptive Biotechnologies Main Business Overview

11.4.5 Adaptive Biotechnologies Latest Developments

11.5 Aethlon Medical

11.5.1 Aethlon Medical Company Information

11.5.2 Aethlon Medical Immuno-oncology Diagnosis Product Offered

11.5.3 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Aethlon Medical Main Business Overview

11.5.5 Aethlon Medical Latest Developments

11.6 Agena Bioscience

11.6.1 Agena Bioscience Company Information

11.6.2 Agena Bioscience Immuno-oncology Diagnosis Product Offered

11.6.3 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Agena Bioscience Main Business Overview

11.6.5 Agena Bioscience Latest Developments

11.7 Angle plc

11.7.1 Angle plc Company Information

11.7.2 Angle plc Immuno-oncology Diagnosis Product Offered

11.7.3 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Angle plc Main Business Overview

11.7.5 Angle plc Latest Developments

11.8 Apocell

11.8.1 Apocell Company Information

11.8.2 Apocell Immuno-oncology Diagnosis Product Offered

11.8.3 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Apocell Main Business Overview

11.8.5 Apocell Latest Developments

11.9 ARUP Laboratories

11.9.1 ARUP Laboratories Company Information

11.9.2 ARUP Laboratories Immuno-oncology Diagnosis Product Offered

11.9.3 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 ARUP Laboratories Main Business Overview

11.9.5 ARUP Laboratories Latest Developments

11.10 Beckman Coulter

11.10.1 Beckman Coulter Company Information

11.10.2 Beckman Coulter Immuno-oncology Diagnosis Product Offered

11.10.3 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Beckman Coulter Main Business Overview

11.10.5 Beckman Coulter Latest Developments

11. Becton Dickinson

11.11.1 Becton Dickinson Company Information

11.11.2 Becton Dickinson Immuno-oncology Diagnosis Product Offered

11.11.3 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Becton Dickinson Main Business Overview

11.11.5 Becton Dickinson Latest Developments

11.12 Bioarray Genetics

11.12.1 Bioarray Genetics Company Information

11.12.2 Bioarray Genetics Immuno-oncology Diagnosis Product Offered

11.12.3 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Bioarray Genetics Main Business Overview

11.12.5 Bioarray Genetics Latest Developments

11.13 BioCartis

11.13.1 BioCartis Company Information

11.13.2 BioCartis Immuno-oncology Diagnosis Product Offered

11.13.3 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 BioCartis Main Business Overview

11.13.5 BioCartis Latest Developments

11.14 Biocept

11.14.1 Biocept Company Information

11.14.2 Biocept Immuno-oncology Diagnosis Product Offered

11.14.3 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Biocept Main Business Overview

11.14.5 Biocept Latest Developments

11.15 Biodesix Inc

11.15.1 Biodesix Inc Company Information

11.15.2 Biodesix Inc Immuno-oncology Diagnosis Product Offered

11.15.3 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Biodesix Inc Main Business Overview

11.15.5 Biodesix Inc Latest Developments

11.16 BioFluidica

11.16.1 BioFluidica Company Information

11.16.2 BioFluidica Immuno-oncology Diagnosis Product Offered

11.16.3 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 BioFluidica Main Business Overview

11.16.5 BioFluidica Latest Developments

11.17 BioGenex 40 bioMérieux

11.17.1 BioGenex 40 bioMérieux Company Information

11.17.2 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product Offered

11.17.3 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 BioGenex 40 bioMérieux Main Business Overview

11.17.5 BioGenex 40 bioMérieux Latest Developments

11.18 Bio-Rad

11.18.1 Bio-Rad Company Information

11.18.2 Bio-Rad Immuno-oncology Diagnosis Product Offered

11.18.3 Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 Bio-Rad Main Business Overview

11.18.5 Bio-Rad Latest Developments

11.19 Bio-Techne

11.19.1 Bio-Techne Company Information

11.19.2 Bio-Techne Immuno-oncology Diagnosis Product Offered

11.19.3 Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Bio-Techne Main Business Overview

11.19.5 Bio-Techne Latest Developments

11.20 Bristol-Myers Squibb

11.20.1 Bristol-Myers Squibb Company Information

11.20.2 Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offered

11.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.20.4 Bristol-Myers Squibb Main Business Overview

11.20.5 Bristol-Myers Squibb Latest Developments

11.21 Cancer Genetics

11.21.1 Cancer Genetics Company Information

11.21.2 Cancer Genetics Immuno-oncology Diagnosis Product Offered

11.21.3 Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.21.4 Cancer Genetics Main Business Overview

11.21.5 Cancer Genetics Latest Developments

11.22 Caris Molecular Diagnostics

11.22.1 Caris Molecular Diagnostics Company Information

11.22.2 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offered

11.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.22.4 Caris Molecular Diagnostics Main Business Overview

11.22.5 Caris Molecular Diagnostics Latest Developments

11.23 CellMax Life

11.23.1 CellMax Life Company Information

11.23.2 CellMax Life Immuno-oncology Diagnosis Product Offered

11.23.3 CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.23.4 CellMax Life Main Business Overview

11.23.5 CellMax Life Latest Developments

11.24 Charles River Laboratories

11.24.1 Charles River Laboratories Company Information

11.24.2 Charles River Laboratories Immuno-oncology Diagnosis Product Offered

11.24.3 Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.24.4 Charles River Laboratories Main Business Overview

11.24.5 Charles River Laboratories Latest Developments

11.25 Chronix Biomedical

11.25.1 Chronix Biomedical Company Information

11.25.2 Chronix Biomedical Immuno-oncology Diagnosis Product Offered

11.25.3 Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.25.4 Chronix Biomedical Main Business Overview

11.25.5 Chronix Biomedical Latest Developments

11.26 Circulogene

11.26.1 Circulogene Company Information

11.26.2 Circulogene Immuno-oncology Diagnosis Product Offered

11.26.3 Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.26.4 Circulogene Main Business Overview

11.26.5 Circulogene Latest Developments

11.27 Clearbridge BioMedics

11.27.1 Clearbridge BioMedics Company Information

11.27.2 Clearbridge BioMedics Immuno-oncology Diagnosis Product Offered

11.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.27.4 Clearbridge BioMedics Main Business Overview

11.27.5 Clearbridge BioMedics Latest Developments

11.28 Clinical Genomics

11.28.1 Clinical Genomics Company Information

11.28.2 Clinical Genomics Immuno-oncology Diagnosis Product Offered

11.28.3 Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.28.4 Clinical Genomics Main Business Overview

11.28.5 Clinical Genomics Latest Developments

11.29 Pfizer

11.29.1 Pfizer Company Information

11.29.2 Pfizer Immuno-oncology Diagnosis Product Offered

11.29.3 Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.29.4 Pfizer Main Business Overview

11.29.5 Pfizer Latest Developments

11.30 Promega

11.30.1 Promega Company Information

11.30.2 Promega Immuno-oncology Diagnosis Product Offered

11.30.3 Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.30.4 Promega Main Business Overview

11.30.5 Promega Latest Developments

11.31 Protagen Diagnostics

11.31.1 Protagen Diagnostics Company Information

11.31.2 Protagen Diagnostics Immuno-oncology Diagnosis Product Offered

11.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.31.4 Protagen Diagnostics Main Business Overview

11.31.5 Protagen Diagnostics Latest Developments

11.32 Qiagen

11.32.1 Qiagen Company Information

11.32.2 Qiagen Immuno-oncology Diagnosis Product Offered

11.32.3 Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.32.4 Qiagen Main Business Overview

11.32.5 Qiagen Latest Developments

11.33 Quanterix

11.33.1 Quanterix Company Information

11.33.2 Quanterix Immuno-oncology Diagnosis Product Offered

11.33.3 Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.33.4 Quanterix Main Business Overview

11.33.5 Quanterix Latest Developments

11.34 Rarecells SAS

11.34.1 Rarecells SAS Company Information

11.34.2 Rarecells SAS Immuno-oncology Diagnosis Product Offered

11.34.3 Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.34.4 Rarecells SAS Main Business Overview

11.34.5 Rarecells SAS Latest Developments

11.35 Roche Diagnostics

11.35.1 Roche Diagnostics Company Information

11.35.2 Roche Diagnostics Immuno-oncology Diagnosis Product Offered

11.35.3 Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.35.4 Roche Diagnostics Main Business Overview

11.35.5 Roche Diagnostics Latest Developments

11.36 Siemens

11.36.1 Siemens Company Information

11.36.2 Siemens Immuno-oncology Diagnosis Product Offered

11.36.3 Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

11.36.4 Siemens Main Business Overview

11.36.5 Siemens Latest Developments

12 Research Findings and Conclusion

Table 1. Immuno-oncology Diagnosis Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of PCR

Table 3. Major Players of NGS

Table 4. Major Players of Immunoassay

Table 5. Immuno-oncology Diagnosis Market Size CAGR by Technology (2020-2026) & ($ Millions)

Table 6. Global Immuno-oncology Diagnosis Market Size by Technology (2016-2021) & ($ Millions)

Table 7. Global Immuno-oncology Diagnosis Market Size Market Share by Technology (2016-2021)

Table 8. Immuno-oncology Diagnosis Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 9. Global Immuno-oncology Diagnosis Market Size by Application (2016-2021) & ($ Millions)

Table 10. Global Immuno-oncology Diagnosis Market Size Market Share by Application (2016-2021)

Table 11. Global Immuno-oncology Diagnosis Revenue by Players (2019-2021E) & ($ Millions)

Table 12. Global Immuno-oncology Diagnosis Revenue Market Share by Players (2019-2021E)

Table 13. Immuno-oncology Diagnosis Key Players Head office and Products Offered

Table 14. Immuno-oncology Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Immuno-oncology Diagnosis Market Size by Regions 2016-2021 & ($ Millions)

Table 18. Global Immuno-oncology Diagnosis Market Size Market Share by Regions 2016-2021

Table 19. Americas Immuno-oncology Diagnosis Market Size by Country (2016-2021) & ($ Millions)

Table 20. Americas Immuno-oncology Diagnosis Market Size Market Share by Country (2016-2021)

Table 21. Americas Immuno-oncology Diagnosis Market Size by Technology (2016-2021) & ($ Millions)

Table 22. Americas Immuno-oncology Diagnosis Market Size Market Share by Technology (2016-2021)

Table 23. Americas Immuno-oncology Diagnosis Market Size by Application (2016-2021) & ($ Millions)

Table 24. Americas Immuno-oncology Diagnosis Market Size Market Share by Application (2016-2021)

Table 25. APAC Immuno-oncology Diagnosis Market Size by Region (2016-2021) & ($ Millions)

Table 26. APAC Immuno-oncology Diagnosis Market Size Market Share by Region (2016-2021)

Table 27. APAC Immuno-oncology Diagnosis Market Size by Technology (2016-2021) & ($ Millions)

Table 28. APAC Immuno-oncology Diagnosis Market Size Market Share by Technology (2016-2021)

Table 29. APAC Immuno-oncology Diagnosis Market Size by Application (2016-2021) & ($ Millions)

Table 30. APAC Immuno-oncology Diagnosis Market Size Market Share by Application (2016-2021)

Table 31. Europe Immuno-oncology Diagnosis Market Size by Country (2016-2021) & ($ Millions)

Table 32. Europe Immuno-oncology Diagnosis Market Size Market Share by Country (2016-2021)

Table 33. Europe Immuno-oncology Diagnosis Market Size by Technology (2016-2021) & ($ Millions)

Table 34. Europe Immuno-oncology Diagnosis Market Size Market Share by Technology (2016-2021)

Table 35. Europe Immuno-oncology Diagnosis Market Size by Application (2016-2021) & ($ Millions)

Table 36. Europe Immuno-oncology Diagnosis Market Size Market Share by Application (2016-2021)

Table 37. Middle East & Africa Immuno-oncology Diagnosis Market Size by Region (2016-2021) & ($ Millions)

Table 38. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Region (2016-2021)

Table 39. Middle East & Africa Immuno-oncology Diagnosis Market Size by Technology (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Technology (2016-2021)

Table 41. Middle East & Africa Immuno-oncology Diagnosis Market Size by Application (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Application (2016-2021)

Table 43. Key and Potential Regions of Immuno-oncology Diagnosis

Table 44. Key Application and Potential Industries of Immuno-oncology Diagnosis

Table 45. Key Challenges of Immuno-oncology Diagnosis

Table 46. Key Trends of Immuno-oncology Diagnosis

Table 47. Global Immuno-oncology Diagnosis Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 48. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Regions (2021-2026)

Table 49. Global Immuno-oncology Diagnosis Market Size Forecast by Technology (2021-2026) & ($ Millions)

Table 50. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Technology (2021-2026)

Table 51. Global Immuno-oncology Diagnosis Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 52. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Application (2021-2026)

Table 53. 10x Genomics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 54. 10x Genomics Immuno-oncology Diagnosis Product Offered

Table 55. 10x Genomics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 56. 10x Genomics Main Business

Table 57. 10x Genomics Latest Developments

Table 58. Abbott Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 59. Abbott Laboratories Immuno-oncology Diagnosis Product Offered

Table 60. Abbott Laboratories Main Business

Table 61. Abbott Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 62. Abbott Laboratories Latest Developments

Table 63. Abcam Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 64. Abcam Immuno-oncology Diagnosis Product Offered

Table 65. Abcam Main Business

Table 66. Abcam Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 67. Abcam Latest Developments

Table 68. Adaptive Biotechnologies Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 69. Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offered

Table 70. Adaptive Biotechnologies Main Business

Table 71. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 72. Adaptive Biotechnologies Latest Developments

Table 73. Aethlon Medical Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 74. Aethlon Medical Immuno-oncology Diagnosis Product Offered

Table 75. Aethlon Medical Main Business

Table 76. Aethlon Medical Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 77. Aethlon Medical Latest Developments

Table 78. Agena Bioscience Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 79. Agena Bioscience Immuno-oncology Diagnosis Product Offered

Table 80. Agena Bioscience Main Business

Table 81. Agena Bioscience Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 82. Agena Bioscience Latest Developments

Table 83. Angle plc Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 84. Angle plc Immuno-oncology Diagnosis Product Offered

Table 85. Angle plc Main Business

Table 86. Angle plc Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 87. Angle plc Latest Developments

Table 88. Apocell Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 89. Apocell Immuno-oncology Diagnosis Product Offered

Table 90. Apocell Main Business

Table 91. Apocell Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 92. Apocell Latest Developments

Table 93. ARUP Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 94. ARUP Laboratories Immuno-oncology Diagnosis Product Offered

Table 95. ARUP Laboratories Main Business

Table 96. ARUP Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 97. ARUP Laboratories Latest Developments

Table 98. Beckman Coulter Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 99. Beckman Coulter Immuno-oncology Diagnosis Product Offered

Table 100. Beckman Coulter Main Business

Table 101. Beckman Coulter Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 102. Beckman Coulter Latest Developments

Table 103. Becton Dickinson Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 104. Becton Dickinson Immuno-oncology Diagnosis Product Offered

Table 105. Becton Dickinson Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 106. Becton Dickinson Main Business

Table 107. Becton Dickinson Latest Developments

Table 108. Bioarray Genetics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 109. Bioarray Genetics Immuno-oncology Diagnosis Product Offered

Table 110. Bioarray Genetics Main Business

Table 111. Bioarray Genetics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 112. Bioarray Genetics Latest Developments

Table 113. BioCartis Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 114. BioCartis Immuno-oncology Diagnosis Product Offered

Table 115. BioCartis Main Business

Table 116. BioCartis Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 117. BioCartis Latest Developments

Table 118. Biocept Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 119. Biocept Immuno-oncology Diagnosis Product Offered

Table 120. Biocept Main Business

Table 121. Biocept Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 122. Biocept Latest Developments

Table 123. Biodesix Inc Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 124. Biodesix Inc Immuno-oncology Diagnosis Product Offered

Table 125. Biodesix Inc Main Business

Table 126. Biodesix Inc Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 127. Biodesix Inc Latest Developments

Table 128. BioFluidica Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 129. BioFluidica Immuno-oncology Diagnosis Product Offered

Table 130. BioFluidica Main Business

Table 131. BioFluidica Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 132. BioFluidica Latest Developments

Table 133. BioGenex 40 bioMérieux Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 134. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product Offered

Table 135. BioGenex 40 bioMérieux Main Business

Table 136. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 137. BioGenex 40 bioMérieux Latest Developments

Table 138. Bio-Rad Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 139. Bio-Rad Immuno-oncology Diagnosis Product Offered

Table 140. Bio-Rad Main Business

Table 141. Bio-Rad Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 142. Bio-Rad Latest Developments

Table 143. Bio-Techne Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 144. Bio-Techne Immuno-oncology Diagnosis Product Offered

Table 145. Bio-Techne Main Business

Table 146. Bio-Techne Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 147. Bio-Techne Latest Developments

Table 148. Bristol-Myers Squibb Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 149. Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offered

Table 150. Bristol-Myers Squibb Main Business

Table 151. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 152. Bristol-Myers Squibb Latest Developments

Table 153. Cancer Genetics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 154. Cancer Genetics Immuno-oncology Diagnosis Product Offered

Table 155. Cancer Genetics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 156. Cancer Genetics Main Business

Table 157. Cancer Genetics Latest Developments

Table 158. Caris Molecular Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 159. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offered

Table 160. Caris Molecular Diagnostics Main Business

Table 161. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 162. Caris Molecular Diagnostics Latest Developments

Table 163. CellMax Life Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 164. CellMax Life Immuno-oncology Diagnosis Product Offered

Table 165. CellMax Life Main Business

Table 166. CellMax Life Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 167. CellMax Life Latest Developments

Table 168. Charles River Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 169. Charles River Laboratories Immuno-oncology Diagnosis Product Offered

Table 170. Charles River Laboratories Main Business

Table 171. Charles River Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 172. Charles River Laboratories Latest Developments

Table 173. Chronix Biomedical Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 174. Chronix Biomedical Immuno-oncology Diagnosis Product Offered

Table 175. Chronix Biomedical Main Business

Table 176. Chronix Biomedical Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 177. Chronix Biomedical Latest Developments

Table 178. Circulogene Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 179. Circulogene Immuno-oncology Diagnosis Product Offered

Table 180. Circulogene Main Business

Table 181. Circulogene Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 182. Circulogene Latest Developments

Table 183. Clearbridge BioMedics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 184. Clearbridge BioMedics Immuno-oncology Diagnosis Product Offered

Table 185. Clearbridge BioMedics Main Business

Table 186. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 187. Clearbridge BioMedics Latest Developments

Table 188. Clinical Genomics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 189. Clinical Genomics Immuno-oncology Diagnosis Product Offered

Table 190. Clinical Genomics Main Business

Table 191. Clinical Genomics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 192. Clinical Genomics Latest Developments

Table 193. Pfizer Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 194. Pfizer Immuno-oncology Diagnosis Product Offered

Table 195. Pfizer Main Business

Table 196. Pfizer Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 197. Pfizer Latest Developments

Table 198. Promega Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 199. Promega Immuno-oncology Diagnosis Product Offered

Table 200. Promega Main Business

Table 201. Promega Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 202. Promega Latest Developments

Table 203. Protagen Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 204. Protagen Diagnostics Immuno-oncology Diagnosis Product Offered

Table 205. Protagen Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 206. Protagen Diagnostics Main Business

Table 207. Protagen Diagnostics Latest Developments

Table 208. Qiagen Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 209. Qiagen Immuno-oncology Diagnosis Product Offered

Table 210. Qiagen Main Business

Table 211. Qiagen Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 212. Qiagen Latest Developments

Table 213. Quanterix Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 214. Quanterix Immuno-oncology Diagnosis Product Offered

Table 215. Quanterix Main Business

Table 216. Quanterix Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 217. Quanterix Latest Developments

Table 218. Rarecells SAS Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 219. Rarecells SAS Immuno-oncology Diagnosis Product Offered

Table 220. Rarecells SAS Main Business

Table 221. Rarecells SAS Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 222. Rarecells SAS Latest Developments

Table 223. Roche Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 224. Roche Diagnostics Immuno-oncology Diagnosis Product Offered

Table 225. Roche Diagnostics Main Business

Table 226. Roche Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 227. Roche Diagnostics Latest Developments

Table 228. Siemens Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors

Table 229. Siemens Immuno-oncology Diagnosis Product Offered

Table 230. Siemens Main Business

Table 231. Siemens Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 232. Siemens Latest Developments

List of Figures

Figure 1. Immuno-oncology Diagnosis Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Immuno-oncology Diagnosis Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Immuno-oncology Diagnosis Market Size Market Share by Technology in 2020

Figure 7. Immuno-oncology Diagnosis in Research

Figure 8. Global Immuno-oncology Diagnosis Market: Research (2016-2021) & ($ Millions)

Figure 9. Immuno-oncology Diagnosis in Diagnostics

Figure 10. Global Immuno-oncology Diagnosis Market: Diagnostics (2016-2021) & ($ Millions)

Figure 11. Global Immuno-oncology Diagnosis Market Size Market Share by Application in 2020

Figure 12. Global Immuno-oncology Diagnosis Revenue Market Share by Player in 2020

Figure 13. Global Immuno-oncology Diagnosis Market Size Market Share by Regions (2016-2021)

Figure 14. Americas Immuno-oncology Diagnosis Market Size 2016-2021 ($ Millions)

Figure 15. APAC Immuno-oncology Diagnosis Market Size 2016-2021 ($ Millions)

Figure 16. Europe Immuno-oncology Diagnosis Market Size 2016-2021 ($ Millions)

Figure 17. Middle East & Africa Immuno-oncology Diagnosis Market Size 2016-2021 ($ Millions)

Figure 18. Americas Immuno-oncology Diagnosis Market Size Market Share by Country in 2020

Figure 19. Americas Immuno-oncology Diagnosis Market Size Market Share by Technology in 2020

Figure 20. Americas Immuno-oncology Diagnosis Market Size Market Share by Application in 2020

Figure 21. United States Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 22. Canada Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 23. Mexico Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 24. APAC Immuno-oncology Diagnosis Market Size Market Share by Regions in 2020

Figure 25. APAC Immuno-oncology Diagnosis Market Size Market Share by Technology in 2020

Figure 26. APAC Immuno-oncology Diagnosis Market Size Market Share by Application in 2020

Figure 27. China Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 28. Japan Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 29. Korea Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 30. Southeast Asia Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 31. India Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 32. Australia Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 33. Europe Immuno-oncology Diagnosis Market Size Market Share by Country in 2020

Figure 34. Europe Immuno-oncology Diagnosis Market Size Market Share by Technology in 2020

Figure 35. Europe Immuno-oncology Diagnosis Market Size Market Share by Application in 2020

Figure 36. Germany Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 37. France Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 38. UK Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 39. Italy Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 40. Russia Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 41. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Region in 2020

Figure 42. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Technology in 2020

Figure 43. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Application in 2020

Figure 44. Egypt Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 45. South Africa Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 46. Israel Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 47. Turkey Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 48. GCC Country Immuno-oncology Diagnosis Market Size Growth 2016-2021 ($ Millions)

Figure 49. Americas Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 50. APAC Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 51. Europe Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 52. Middle East & Africa Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 53. United States Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 54. Canada Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 55. Mexico Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 56. Brazil Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 57. China Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 58. Japan Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 59. Korea Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 60. Southeast Asia Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 61. India Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 62. Australia Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 63. Germany Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 64. France Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 65. UK Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 66. Italy Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 67. Russia Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 68. Spain Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 69. Egypt Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 70. South Africa Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 71. Israel Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 72. Turkey Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)

Figure 73. GCC Country Immuno-oncology Diagnosis Market Size 2021-2026 ($ Millions)